Search
for
Sort by
Research 61–90 of 1000+
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Baricitinib-Induced Trichilemmal Cyst Reactivation in a Woman With Alopecia Areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- A novel therapeutic paradigm for patients with extensive alopecia areata
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- UHPLC-Q-Orbitrap HRMS-based Metabolomics and In Silico Studies on 5-α-Reductase, JAK1, JAK2, and JAK3 of <i>Albizia saponaria</i> L.: Application to Alopecia
- Environmental Modulation of JAK3-Mediated Immune Dysregulation in Alopecia Areata
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Treating Alopecia Areata: Current Practices Versus New Directions
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- Mechanisms of autophagy and their implications in dermatological disorders
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Leptin and the skin: a new frontier
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata